Highlights JW Pharmaceutical Corporation

Equities

A001060

KR7001060003

End-of-day quote Korea S.E. Other stock markets 03:30:00 23/05/2024 am IST			5-day change	1st Jan Change
29,500 ^KRW	+0.68%		-2.96%	-17.02%

14/03	JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
22/01	CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	14/03	CI
CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions	22/01	MT
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
JW Pharmaceutical Faces Potential Fine of Nearly 30 Billion Won for Alleged Illegal Rebates	20/23/20	MT
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Celleron Therapeutics Ltd acquired Argonaut Therapeutics Limited from JW Pharmaceutical Corporation and Oxford Science Enterprises.	05/23/05	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
JW Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	21/22/21	CI
JW Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
Market Chatter: JW Pharmaceutical Gets German Health Body's Permit for Phase 2a Study of Oral Atopic Dermatitis Drug	21/21/21	MT
Market Chatter: South Korean Drugmakers Queue Up for Clearance of COVID-19 Treatments in January	04/21/04	MT
JW Pharmaceutical Corporation completed the acquisition of 50% stake in C&C Research Laboratories from Chugai Pharmaceutical Co., Ltd.	31/19/31	CI
JW Pharmaceutical Corporation agreed to acquire the remaining 50% stake in C&C Research Laboratories from Chugai Pharmaceutical Co., Ltd..	27/19/27	CI
Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China	27/19/27	CI
JW Pharmaceutical Corporation acquired Euvipharm Pharmaceutical Joint-Stock Company.	04/19/04	CI
LEO Pharma and JW Pharmaceutical Corporation Files IND Application to FDA for a Clinical Study of JW1601/LP0190 in the US	27/19/27	CI
Tranche Update on JW Pharmaceutical Corporation's Equity Buyback Plan announced on September 12, 2018.	30/18/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights JW Pharmaceutical Corporation

Equities

A001060

KR7001060003

Highlights

Filters